Pages that link to "Q28255756"
Jump to navigation
Jump to search
The following pages link to Fecal microbiota transplantation and emerging applications (Q28255756):
Displaying 50 items.
- Probiotics and irritable bowel syndrome (Q24616349) (← links)
- Therapeutic faecal microbiota transplantation: current status and future developments (Q24629302) (← links)
- Pathogenic role of the gut microbiota in gastrointestinal diseases (Q26749878) (← links)
- Fecal microbiota transplantation: in perspective (Q26765214) (← links)
- The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation (Q26765740) (← links)
- Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior (Q26766519) (← links)
- Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis (Q26771942) (← links)
- Fecal microbiota transplantation: indications, methods, evidence, and future directions (Q26830134) (← links)
- Coral-associated micro-organisms and their roles in promoting coral health and thwarting diseases (Q26849786) (← links)
- Inflammatory bowel disease as a model for translating the microbiome (Q26853123) (← links)
- Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system (Q26853628) (← links)
- Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children (Q26859859) (← links)
- Current status and future promise of the human microbiome (Q26865656) (← links)
- Emerging infectious diseases in 2012: 20 years after the institute of medicine report (Q26866454) (← links)
- Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs (Q26995670) (← links)
- Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis (Q27001712) (← links)
- Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection (Q27009228) (← links)
- Cross-talk between bile acids and intestinal microbiota in host metabolism and health (Q27026925) (← links)
- Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate (Q28072437) (← links)
- From next-generation sequencing to systematic modeling of the gut microbiome (Q28082185) (← links)
- Minireview: Gut microbiota: the neglected endocrine organ (Q28241240) (← links)
- Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases (Q28552586) (← links)
- Can probiotics modulate human disease by impacting intestinal barrier function? (Q28817192) (← links)
- The intestinal microbiome and surgical disease. (Q30248605) (← links)
- Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene (Q31080187) (← links)
- Functional and phylogenetic assembly of microbial communities in the human microbiome (Q33560652) (← links)
- Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation (Q33648414) (← links)
- Fecal microbiota transplantation: an interview with alexander khoruts (Q33648559) (← links)
- The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal (Q33662740) (← links)
- How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study (Q33749944) (← links)
- Translational Rodent Models for Research on Parasitic Protozoa-A Review of Confounders and Possibilities (Q33770491) (← links)
- The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? (Q33810037) (← links)
- Role of the gut microbiota in immunity and inflammatory disease (Q34036490) (← links)
- Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics (Q34311685) (← links)
- Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? (Q34419563) (← links)
- From stool transplants to next-generation microbiota therapeutics (Q34458414) (← links)
- Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice (Q34468946) (← links)
- Microbial ecosystems therapeutics: a new paradigm in medicine? (Q34519313) (← links)
- Modulation of systemic immune responses through commensal gastrointestinal microbiota (Q34552011) (← links)
- High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria (Q34554969) (← links)
- Human genetics shape the gut microbiome. (Q34630305) (← links)
- Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. (Q34649546) (← links)
- Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes (Q34662533) (← links)
- Fecal microbiota transplantation broadening its application beyond intestinal disorders (Q34667433) (← links)
- Patient perceptions of fecal microbiota transplantation for ulcerative colitis (Q34691746) (← links)
- The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. (Q34722114) (← links)
- Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease (Q34813567) (← links)
- Fecal transplant policy and legislation (Q34827720) (← links)
- Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. (Q34960559) (← links)
- Antimicrobial peptides and gut microbiota in homeostasis and pathology. (Q34987870) (← links)